Eligible patients had initiated treatment and had 1 pharmacy claim of any dose strength of semaglutide 2.4 mg or tirzepatide in the US Komodo Health database between June 4, 2021 (approval date of semaglutide 2.4 mg), and December 15, 2023
E.FarbT
In the daily clinical practice of the consensus panel members, the ketogenic diet is proposed for 80100% of patients with GLUT1 deficiency syndrome, 3050% of patients with early infantile developmental and epileptic encephalopathy, 2530% of patients with PDH deficiency and tuberous sclerosis complex
~ AlphaMD Your doctor mentions your PSA came back elevated, and before you can ask a single question, your brain jumps straight to the worst-case scenario
"ARTHRITIS UPDATE: Drugs That Inhibit COX-2 May Cause Tissue Damage" Life Extension magazine, 1/2001
GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists: strengthened warnings on acute pancreatitis, including necrotising and fatal cases [Internet]